US Patent Issued to LETO LABORATORIES on May 12 for "Modified interleukin-2 (IL-2) molecule and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,078, issued on May 12, was assigned to LETO LABORATORIES Co. LTD (Beijing).

"Modified interleukin-2 (IL-2) molecule and use thereof" was invented by Yao Zhao (Beijing), Yu Zhang (Beijing), Huijie Liu (Beijing), Jinhua Piao (Beijing), Jianjun Zhang (Beijing), Qiulei Zhang (Beijing), Wei Zhang (Beijing), Guoyong Wang (Beijing) and Tianfu Zhang (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "A modified interleukin-2 (IL-2) molecule is obtained by being subjected to a modification as follows: substituting a region in an IL-2 molecule that mediates the binding of the IL-2 molecule to interleukin-2 receptor alpha (IL2RAlpha) with a region in an int...